Laura Rodriguez

Partner · Invivo Partners · company speakers →

<p>Partner at Invivo Partners, she joined the firm in January 2018. Invivo Partners is a venture capital firm specializing in early-stage life sciences companies. The firm recently announced its third fund, targeting €100 million for investments in early-stage life science companies, with a particular focus on advanced therapies.</p> <p>She serves as a Member of the Board of Directors at OneChain, Telomere Therapeutics, Esobiotec and SIgnadori Bio, and as an Observer at Arthex, Pulmobiotics, Gyala Therapeutics, and Telum.</p> <p>Previously, she worked as a Project Manager in the Knowledge Transfer and Innovation Unit at the Research Institute of the Vall d'Hebron Hospital (VHIR) in Barcelona.</p> <p>She has five years of R&amp;D experience in oncology and gene therapy, which has led to publications in peer-reviewed journals and collaborations with biotechnology companies.</p> <p>She holds a BSc in Biotechnology from the Autonomous University of Barcelona (UAB), a PhD in Biotechnology from the University of Barcelona (UB), and has completed a postgraduate course in Innovation Management at UAB.</p>

Is this you? Claim this profile →